Ewing's sarcoma family of tumors: An overview from diagnosis to survivorship

Clinical Journal of Oncology Nursing

Volumn 12, Issue 1, 2008, Pages 89-97

  Lahl, Meredith ^a   Fisher, Vicki L ^b   Laschinger, Kelly ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; BONE TUMOR; CHILD; EWING SARCOMA; HUMAN; INCIDENCE; MULTIMODALITY CANCER THERAPY; NURSE ATTITUDE; NURSING; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; PROGNOSIS; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; HUMANS; INCIDENCE; NURSE'S ROLE; ONCOLOGIC NURSING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SARCOMA, EWING'S; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 42949117919     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/08.CJON.89-97     Document Type: Article

References (25)

1. Albin, A. (1997). Supportive care of children with cancer: Current therapy and guidelines from the Children's Oncology Group (2nd ed.). Baltimore: Johns Hopkins University Press.
2. Baggott, C.R., Kelly, K.P., Fochtman, D., & Foley, G.V. (2002). Nursing care of children and adolescents with cancer (3rd ed.). Philadelphia: Saunders.
3. Bloch, A. (2000). Nutrition support in cancer. Seminars in Oncology Nursing, 16(2), 122-127.
4. Bottomley, S.J., & Kassner, E. (2003). Late effects of childhood cancer therapy. Journal of Pediatric Nursing, 18(2), 126-133.
5. Gibbs, I.C., Tuamokumo, N., & Yock, T.I. (2006). Role of radiation therapy in pediatric cancer. Hematology/Oncology Clinics of North America, 20(2), 455-470.
6. Grier, H.E. (1997). The Ewing family of tumors: Ewing's sarcoma and primitive neuroectodermal tumors. Pediatric Clinics of North America, 44(4), 991-1004.
7. Grier, H.E., Krailo, M.D., Tarbell, N.J., Link, M.P., Fryer, C.J., Prit-chard, D.J., et al. (2003). Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neu-roectodermal tumor of bone. New England Journal of Medicine, 348(8), 694-701.
8. ®: Mucositis. Pittsburgh, PA: Oncology Nursing Society.
9. Hockenberry-Eaton, M., Hinds, P.S., Alcoser, P., O'Neill, J.B., Euell, K., Howard, V., et al. (1998). Fatigue in children and adolescents with cancer. Journal of Pediatric Oncology Nursing, 15(3), 172-182.
10. Horowitz, M.E., Tsokos, M.G., & DeLaney, T.F. (1992). Ewing's sarcoma. CA: A Cancer Journal for Clinicians, 42(5), 300-320.
11. Kushner, B.H., & Meyers, P.A. (2001). How effective is dose-inten-sive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. Journal of Clinical Oncology, 19(3), 870-880.
12. Lanzkowsky, P. (2005). Manual of pediatric hematology and oncology (4th ed.). New York: Churchill Livingstone.
13. Marina, N.M., Pappo, A.S., Parham, D.M., Cain, A.M., Rao, B.N., Poquette, C.A., et al. (1999). Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmo-plastic small round-cell tumors: A feasibility study at St. Jude Children's Research Hospital. Journal of Clinical Oncology, 17 (1), 180-190.
14. Martin, R.C., II, & Brennan, M.F. (2003). Adult soft tissue Ewing sarcoma or primative neuroectodermal tumors: Predictors of survival? Archives of Surgery, 138(3), 281-285.
15. Miser, J.S., Krailo, M.D., Tarbell, N.J., Link, M.P., Fryer, C.J., Prit-chard, D.J., et al. (2004). Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: Evaluation of combination ifosfamide & etoposide-A Children's Cancer Group and Pediatric Oncology Group study. Journal of Clinical Oncology, 22(14), 2873-2876.
16. ®: Fatigue. Pittsburgh, PA: Oncology Nursing Society.
17. Nagarajan, R., Neglia, J.P., Clohisy, D.R., Yasui, Y., Greenberg, M., Hudson, M., et al. (2003). Education, employment, insurance, and marital status among 694 survivors of pediatric lower extremity bone tumors: A report from the Childhood Cancer Survivor Study. Cancer, 97(10), 2554-2564.
18. Nesbit, M.E., Jr., Gehan, E.A., Burgert, E.O., Jr., Vietti, T.J., Cangir, A., Tefft, M., et al. (1990). Multimodal therapy for the management of primary, non-metastatic Ewing's sarcoma of bone: A long-term follow-up of the first intergroup study. Journal of Clinical Oncology, 8(10), 1664-1674.
19. Pizzo, P.A., & Poplack, D.G. (2005). Principles and practice of pediatric oncology (5th ed.). Philadelphia: Lippincott Williams and Wilkins.
20. Sluga, M., Windhager, R., Lang, S., Heinzl, H., Krepler, P., Mitter-mayer, F., et al. (2001). The role of surgery and resection margins in the treatment of Ewing's sarcoma. Clinical Orthopaedics and Related Research, 392, 394-399.
21. ®: Nausea and vomiting. Pittsburgh, PA: Oncology Nursing Society.
22. Tisdale, M.J. (1991). Cancer cachexia. British Journal of Cancer, 63(3), 337-342.
23. Tyc, V.L., Vallelunga, L., Mahoney, S., Smith, B.F., & Mulhern, R.K. (1995). Nutritional and treatment-related characteristics of pediatric oncology patients referred or not referred for nutritional support. Medical and Pediatric Oncology, 25(5), 379-388.
24. ®: Peripheral neuropathy. Pittsburgh, PA: Oncology Nursing Society.
25. Womer, R.B., Daller, R.T., Fenton, J.G., & Miser, J.S. (2000). Granu-locyte colony stimulating factor permits dose intensifcation by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children. European Journal of Cancer, 36(1), 87-94.